Skip to main content

Advertisement

SpringerLink
Log in

Colorectal metastases to the liver: Present status of management

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The management of patients with hepatic metastases from colorectal carcinoma is controversial. While a “no treatment” attitude still persists, other patients undergo systemic chemotherapy with very limited results. Other possible options are hepatic resection and locoregional treatments. One hundred twenty-three patients with hepatic metastases from colorectal cancer were treated at the authors' institution over a period of 15 years. Thirty-nine patients underwent hepatic resection while 84 underwent various forms of locoregional treatment. Several patients in the latter group were registered in one national (RNSI) Phase 2 study and one international (EORTC Phase 3 trial. The authors' experience confirms the opinion that hepatic resection can be performed with the aim of curing in patients with isolated metastases. A five-year survival rate can be achieved in 25 to 30 percent of the resectable patients. Patients with unresectable extrahepatic disease or multiple bilateral metastases are usually excluded from resection. In other cases, hepatic resection should be carried out when technically possible. The value of adjuvant chemotherapy to the remaining liver has to be tested in prospective randomized trials. Patients with diffuse metastases can benefit from locoregional infusion of chemotherapeutic agents. Symptoms improve in most patients; objective responses vary from 53 to 83 percent of the cases, which is a higher rate than that reported for systemic chemotherapy. Survival may be prolonged in respect to untreated patients but this has not been demonstrated yet by prospective randomized studies. Current trends are continuous infusion of chemotherapeutic agents and experimentation of new drugs or drug combinations. Future improvements may be achieved by adding hepatic arterial ischemia, hyperthermia, or radiation therapy. As these kinds of treatments are still experimental, they should be applied to the patients only in the context of prospective clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma verified by laparotomy. Cancer 1969;23:198–202.

    Google Scholar 

  2. Morris MJ, Newland RC, Pheils MT, MacPherson JG. Hepatic metastases from colorectal carcinoma: an analysis of survival rates and histopathology. Aust NZ J Surg 1977;47:365–8.

    Google Scholar 

  3. Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285–8.

    Google Scholar 

  4. August DA, Sugarbaker PH, Ottow RT. Hepatic resection of colorectal metastases. Ann Surg 1985;201:210–8.

    Google Scholar 

  5. Jaffe' N, Donegan WL, Wattson F, Spratt JS. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1986;127:1–11.

    Google Scholar 

  6. Nielsen J, Balslev I, Jensen HE. Carcinoma of the colon with liver metastases. Acta Chir Scand 1971;137:463–5.

    Google Scholar 

  7. Adson MA, Van Heerden JA, Adson MH. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984;119:647–51.

    Google Scholar 

  8. Butler J, Attiyeh FF, Daly J. Hepatic resection for metastases of the colon and rectum. Surg Gynecol Obstet 1986;162:109–13.

    Google Scholar 

  9. Cady B, McDermott WV. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 1985;201:204–9.

    Google Scholar 

  10. Kemeny N, Yagoda A, Braun D. Metastatic colorectal carcinoma: a prospective randomized trial of Methyl CCNN, 5 fluorouracil (5FU) and Vincristine (MOF) versus MOF plus steptozotocin (MOF-strept). Cancer 1983;51:20–5.

    Google Scholar 

  11. Loehrer PJ, Einhorn CH, Williams SD, Hui SL, Estes NC, Pennington K. Cisplatin plus 5FU for the treatment of adenocarcinoma of the colon. Cancer Treat Res 1985;69:1359–63.

    Google Scholar 

  12. Ensminger WD, Gyves JV. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983;10:176–81.

    Google Scholar 

  13. Balch CM, Urist MM, Soong S, McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983;198:567–73.

    Google Scholar 

  14. Ensminger W, Niederhuber J, Gyves J, Thrall J. Effective control of liver metastases from colon cancer with an implanted system for hepatic arterial chemotherapy. Proc Am Soc Clin Oncol 1982;1:94.

    Google Scholar 

  15. Niederhuber JE, Ensminger W, Gyves J, Throll J, Walker S, Lozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984;53:1336–53.

    Google Scholar 

  16. Fortner JG, MacLean BJ, Kim DK. The seventies evolution in liver surgery for cancer. Cancer 1981;47:2162–6.

    Google Scholar 

  17. Rajpal S, Damahapatra KS, Ledesma EG, Mittelman A. Extensive resections of isolated metastases from carcinoma of the colon and rectum. Surg Gynecol Obstet 1986;155:813–6.

    Google Scholar 

  18. Sesto ME, Vogt DP, Herman RE. Hepatic resection in 128 patients: a 24 year experience. Surgery 1987;102:846–51.

    Google Scholar 

  19. Nordlinger B, Qulichini MA, Parc R, Hannaunl, Delva E, Huguet C. Hepatic resection for colorectal liver metastases. Ann Surg 1987;205:256–63.

    Google Scholar 

  20. Iwatsuki S, Esquivel CD, Gordon RD, Starzl TE. Liver resection for metastatic colorectal cancer. Surgery 1986;100:804–10.

    Google Scholar 

  21. Wilson SM, Adson MA. Surgical treatment of hepatic metastases from colorectal cancers. Arch Surg 1976;11:330–4.

    Google Scholar 

  22. Attiyeh FF, Wanebo HJ, Stearns MW. Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum 1978;21:160–2.

    Google Scholar 

  23. Morrow CE, Grage TB, Sutherland DE, Najarian J. Hepatic resection for secondary neoplasm. Surgery 1984;92:610–14.

    Google Scholar 

  24. Taylor BR, Langer B, Falk RE, Ambus U. Role of resection in the management of metastases to the liver. Can J Surg 1983;26:215–7.

    Google Scholar 

  25. Wanebo HJ, Semoglou C, Attiyeh F, Stearns MW. Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 1978;135:81–5.

    Google Scholar 

  26. Couburn CS, Makowka L, Langer B, Taylor BR, Falk RE. Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 1987;165:239–46.

    Google Scholar 

  27. Fortner JG, Silva JS, Golbey RB, Cox EB, MacLean BJ. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer I: treatment by hepatic resection. Ann Surg 1984;199:306–16.

    Google Scholar 

  28. Olak J, Wexler MJ, Rodriguez J, McLean AP. Hepatic resection for metastatic disease. Can J Surg 1986;29:435–9.

    Google Scholar 

  29. Registry of Hepatic Metastases. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988;103:278–88.

    Google Scholar 

  30. Hodgson WJ, Mittelman A, Katz S, et al. Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic diseases. Ann Surg 1986;203:420–5.

    Google Scholar 

  31. Patt YZ, McBride CM, Ames FC, et al. Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 1987;59:867–73.

    Google Scholar 

  32. Bengmark S, Fredland P, Hafstorm LO, Vang J. Present experiences with hepatic dearterialization in liver neoplasm. Prog Surg 1974;13:141–6.

    Google Scholar 

  33. Patt YZ, Chuang VP. The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic liver. Lancet 1981;1:349–50.

    Google Scholar 

  34. Taylor I. Cytotoxic perfusion for colorectal liver metastases Br J Surg 1978;65:109–114.

    Google Scholar 

  35. Watkins E, Klazei AM, Wahua KS. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 1970;130:581–605.

    Google Scholar 

  36. Lise M, Cagol PP, Nitti D, et al. Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver. Int Surg 1980;65:315–23.

    Google Scholar 

  37. Registro Nazionale Sistemi Impiantabili (RNSI). Cavaliere R., Bologna 1988. Personal comunication.

  38. Gerard A, Dalesio O, Duez N, et al. Hepatic arterial ligation widi and without portal infusion in metastatic colorectal cancer. Recent Results Cancer Res 1988;100:181–6.

    Google Scholar 

  39. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 1987;107:459–65.

    Google Scholar 

  40. Chang AE, Schreider PP, Sugarbaker PH. A prospective ramdomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685–93.

    Google Scholar 

  41. Hohn D, Stagg R, Friedman M, et al. The NCOG randomized trial of intravenous (IV) vs hepatic arterial (IA) FUDR for colorectal cancer metastatic to the liver. ASCO Proc 1987;6:85.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Patologia Chirurgica I, Universita' Degli Studi di Padova, Padova, Italy

    M. Lise M.D., P. P. Da Pian M.D., D. Nitti M.D., P. L. Pilati M.D. & C. Prevaldi M.D.

Authors
  1. M. Lise M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. P. Da Pian M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Nitti M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. L. Pilati M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Prevaldi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Read at the XIIth Biennial Congress of the International Society of University Colon and Rectal Surgeons, Glasgow, Scotland, July 10 to 14, 1988.

About this article

Cite this article

Lise, M., Da Pian, P.P., Nitti, D. et al. Colorectal metastases to the liver: Present status of management. Dis Colon Rectum 33, 688–694 (1990). https://doi.org/10.1007/BF02150746

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02150746

Key words

Search

Navigation